Standardizing chronic graft-versus-host disease

Future Oncology

Volumn 2, Issue 4, 2006, Pages 459-462

  van Besien, Koen ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Biomarkers; Bone marrow transplantation; Chronic graft versus host disease; Response criteria; Stem cell transplant

Indexed keywords

BILIRUBIN; BIOLOGICAL MARKER; CORTICOSTEROID; HLA ANTIGEN; INTERLEUKIN 10;

ALLOTRANSPLANTATION; ARTICLE; BILIRUBIN BLOOD LEVEL; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONSENSUS DEVELOPMENT; CORTICOSTEROID INDUCED MYOPATHY; DISEASE SEVERITY; GENETIC POLYMORPHISM; GRAFT VERSUS LEUKEMIA EFFECT; GYNECOLOGIC DISEASE; HISTOPATHOLOGY; HLA MATCHING; HUMAN; HYPERCHOLESTEROLEMIA; MEDICAL LITERATURE; METHODOLOGY; MORTALITY; OPPORTUNISTIC INFECTION; OSTEOPOROSIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENT DISEASE; STAGING; STANDARDIZATION; THROMBOCYTE COUNT;

CLINICAL TRIALS; GRAFT VS HOST DISEASE; HUMANS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33748111705     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/14796694.2.4.459     Document Type: Article

References (7)

1. Pavletic S, Vogelsang G: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: preface to the series. Biol. Blood Marrow Transplant. 11(12), 943-944 (2005).
2. Filipovich AH, Weisdorf D, Pavletic S et al.: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol. Blood Marrow Transplant. 11(12), 945-956 (2005).
3. Shulman HM, Kleiner D, Lee SJ et al.: Histopathologic diagnosis of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. Pathology Working Group Report. Biol. Blood Marrow Transplant. 12(1), 31-47 (2006).
4. Schultz KR, Miklos DB, Fowler D et al.: Toward biomarkers for chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: III. Biomarker Working Group Report. Biol. Blood Marrow Transplant. 12(2), 126-137 (2006).
5. Pavletic SZ, Martin P, Lee SJ et al.: Measuring therapeutic response in chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: IV. Response Criteria Working Group report. Biol. Blood Marrow Transplant. 12(3), 252-266 (2006).
6. Couriel D, Carpenter PA, Cutler C et al: Ancillary therapy and supportive care of chronic graft-versus-host disease: National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: V. Ancillary Therapy and Supportive Care Working Group Report. Biol. Blood Marrow Transplant. 12(4), 375-396 (2006).
7. Martin PJ, Weisdorf D, Przepiorka D et al.: Design of Clinical Trials Working Group National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: VI. Design of Clinical Trials Working Group report. Biol. Blood Marrow Transplant. 12(5), 491-505 (2006).